Crystal structure of [2-(2-hydroxybenzilydene)-hydrazinecarboxoamidato(1-)][2-(2-hydroxybenzilydene)-hydrazinecarboxoamidato(2-)]chromium monohydrate

The crystal structure of [2-(2-hydroxybenzilydene)hydrazinecarboxoamidato(1-)][2-(2-hydroxy-benzilydene)hydrazinecarboxoamidato(2-)]chromium monohydrate [Cr(HL)(L)]·H₂O (I), where H₂L is salicylaldehyde semicarbazone, is determined. In I the central chromium atom is octahedrally surrounded by two ligand anions in the mer position and coordinated azomethine nitrogen atoms, phenol and carbamide oxygen atoms. In both ligands phenol groups are deprotonated; in one of them the imine group is also deprotonated. In the crystal, complexes of the compound studied are hydrogen bonded into layers along the [100] direction, with π-π stacking being observed between the phenyl rings inside the layer along with the X-H…Cg (π ring) interaction.     

A facile synthesis of novel 3-(aryl/alkyl-2-ylmethyl)-2-thioxothiazolidin-4-ones using microwave heating

(Z)-5-(2-(1H-Indol-3-yl)-2-oxoethylidene)-3-(aryl/alkyl-2-ylmethyl)-2-thioxothiazolidin-4-ones (7a–w) have been synthesized by the Knoevenagel condensation reaction of 3-(aryl/alkyl-2-ylmethyl)-2-thioxothiazolidin-4-ones (3a–d) with suitably substituted 2-(1H-indol-3-yl)2-oxoacetaldehydes (6a–g) under microwave conditions. The thioxothiazolidin-4-ones were prepared from the corresponding aryl/alkyl amines (1a–d) and di-(carboxymethyl)-trithiocarbonyl (2). The aldehydes (6a–g) were synthesized from the corresponding acid chlorides (5a–g) using HsnBu₃.     

Dibutyltin(IV) complexes of the 5-[(E)-2-(Aryl)-1-diazenyl]-2-hydroxybenzoic acid ligand: an investigation of structures by X-ray diffraction, solution and solid state tin NMR, electrospray ionisation MS and assessment of in vitro cytotoxicity

A series of dibutylbis{5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoato}tin(IV) complexes, Bu₂Sn(LH)₂, have been prepared and characterized by ¹H, ¹³C, ¹¹⁹Sn NMR and ESI mass spectrometry in solution. The structures of the complexes Bu₂Sn(L¹H)₂ (1), Bu₂Sn(L³H)₂ (3), Bu₂Sn(L⁴H)₂ (4), and Bu₂Sn(L⁶H)₂ (6) (L = 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoate: aryl = phenyl (L¹H), 3-methylphenyl (L³H), 4-methylphenyl (L⁴H) and 4-bromophenyl (L⁶H)) were determined by X-ray crystallography and ¹¹⁷Sn CP-MAS NMR spectroscopy in the solid state. In general, the complexes were found to adopt a skew-trapezoidal bipyramidal arrangement around the tin atom. In addition, there are weak bridging intermolecular Sn?O contacts in complexes 1 and 3, but not in 4 and 6, where one of the hydroxy oxygen atoms from a neighboring molecule coordinates weakly with the Sn atom, thereby completing a seventh coordination site in the extended Sn coordination sphere. The Sn?O distance is 3.080(2) and 3.439(2) Å in 1 and 3, respectively, which are significantly shorter than the sum of the van der Waals radii of the Sn and O atoms (∼3.8 Å). In 1, this Sn?O interaction links the molecules into polymeric chains. In 3, these interactions link pairs of molecules into head-to-head dimeric units. The in vitro cytotoxicity of compound 2 indicates better results than cisplatin and etoposide against seven well characterized human tumor cell lines.     

Self-assembly of extended Schiff base amino acetate skeletons, 2-{[(2Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}phenylpropionate and 2-{[(E)-1-(2-hydroxyaryl)alkylidene]amino}phenylpropionate skeletons incorporating organotin(IV) moieties: Synthesis,spectroscopic characterization,crystal structures,and in vitro cytotoxic activity

The organotin(IV) compounds, [Ph₃SnL¹H]_n · nCCl₄ (1), [Me₂SnL²(OH₂)] (2), [ⁿBu₂SnL²] (3), [Ph₂SnL²]_n (4), [Ph₃SnL²H]_n (5) and [Ph₃SnL³H]_n (7) (L¹ = 2-{[(2Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}phenylpropionate and L²⁻³ = 2-{[(E)-1-(2-hydroxyaryl)alkylidene]amino}phenylpropionate), were synthesized by treating the appropriate organotin(IV) chloride(s) with the potassium salt of the ligand in a suitable solvent, while [ⁿBu₂SnL³(OH₂)] (6) was obtained by reacting the acid form of L³ (generated in situ) with ⁿBu₂SnO. These complexes have been characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, ESI-MS, IR and ^119mSn Mössbauer spectroscopic techniques in combination with elemental analyses. The crystal structures of 1 and 4–7 were determined. The crystal structures of complexes 1, 5 and 7 reveal that the complexes exist as polymeric chains in which the L-bridged Sn-atoms adopt a trans-R₃SnO₂ trigonal bipyramidal configuration with R groups in the equatorial positions and the axial locations occupied by a carboxylate oxygen from the carboxylate ligand and the alcoholic or phenolic oxygen of the next carboxylate ligand in the chain. The carboxylate ligands coordinate in the zwitterionic form with the alcoholic/phenolic proton moved to the nearby nitrogen atom. A polymeric zig-zag cis-bridged chain structure is observed for 4, without considering the weak Sn⋯O interaction, the Sn-atom having a slightly distorted trigonal bipyramidal coordination geometry with the two O atoms of the tridentate amino propionate ligand in axial positions. On the other hand, the structure of 6 reveals a monomeric molecule in which the Sn-atom has a distorted octahedral coordination geometry involving the tridentate carboxylate ligand, two n-butyl ligands occupying trans-positions and one water ligand. The in vitro cytotoxic activity of triphenyltin(IV) compounds, viz., 1, 5 and 7 against WIDR, M19 MEL, A498, IGROV, H226, MCF7 and EVSA-T human tumor cell lines are also reported.     

Untersuchungen über Synthesewege zu 2-Äthynyl-2-cyclopenten-1-onen

Synthetic approaches to 2-ethynyl-2-cyclopenten-1-ones (A) by dehydratation of the readily obtainable 2-(1-alkynyl)-2-hydroxy-cyclopentanones1 a and1 b were investigated. The synthesis of 2-(3,3,3-triphenylpropynyl)-2-cyclopenten-1-one (6) was achieved by reaction of 1-(3,3,3-triphenylpropynyl)-6-oxabicyclo[3.1.0]hexane (3 b) with HCl and CrO₃-oxidation of the resulting 2-(3,3,3-triphenylpropynyl)-2-cyclopenten-1-ol (4).     

Influence of intermolecular interactions on the conformation of a 2-[bis(2-ethylphenyl)thiophosphorylhydroxymethyl]-1-ethylbenzimidazole molecule (L) upon complex formation with ZnCl2: Crystal and molecular structures of molecule L

The structures and conformations of a 2-[bis(2-ethylphenyl)thiophosphorylhydroxymethyl]-1-ethylbenzimidazole (L) molecule in the free form (L_fr) and in the [ZnCl₂L]L complex (I) are compared using the X-ray diffraction data. In complex I, one ligand molecule (L_c) is coordinated to the zinc atom in the bidentate chelating mode and the second molecule (L_solv) accomplishes the solvating function. An isomer with the cis orientation of the O(1) atom to the N(1) atom is observed in the crystal structure of L_fr, like L_solv in complex I, with the formation of the five-membered corrugated H-heterocycle OC₂NH. L_fr and L_solv molecules differ in the arrangement of the aromatic rings of the 2R substituent of benzimidazole. Crystalline compound L forms dimeric associates in which three conjugate H-rings are closed by a bifurcate intermolecular hydrogen bond: two five-membered ONC₂H rings and one planar four-membered N₂H₂ ring ((N(1)…N(1A), 3.705 and H(1)…H(1A) 2.67 Å). Unlike crystals of compound I with the π-π-stacking interaction between the planar-parallel aromatic rings of benzimidazole of the L_solv and L_c molecules, the crystals of L have no similar interaction between the L_fr molecules.     

Syntheses and structures of iron carbonyl complexes derived from N-(5-methyl-2-thienylmethylidene)-2-thiolethylamine and N-(6-methyl-2-pyridylmethylidene)-2-thiolethylamine

The reaction of N-(5-methyl-2-thienylmethylidene)-2-thiolethylamine (1) with Fe₂(CO)₉ in refluxing acetonitrile yielded di-(μ₃-thia)nonacarbonyltriiron (2), μ-[N-(5-methyl-2-thienylmethyl)-η¹:η¹(N);η¹:η¹(S)-2-thiolatoethylamido]hexacarbonyldiiron (3), and N-(5-methyl-2-thienylmethylidene)amine (4). If the reaction was carried out at 45 °C, di-μ-[N-(5-methyl-2-thienylmethylidene)-η¹(N);η¹(S)-2-thiolethylamino]-μ-carbonyl-tetracarbonyldiiron (5) and trace amount of 4 were obtained. Stirring 5 in refluxing acetonitrile led to the thermal decomposition of 5, and ligand 1 was recovered quantitatively. However, in the presence of excess amount of Fe₂(CO)₉ in refluxing acetonitrile, complex 5 was converted into 2-4. On the other hand, the reaction of N-(6-methyl-2-pyridylmethylidene)-2-thiolethylamine (6) with Fe₂(CO)₉ in refluxing acetonitrile produced 2, μ-[N-(6-methyl-2-pyridylmethyl)-η¹ (N_py);η¹:η¹(N); η¹:η¹(S)-2-thiolatoethylamido]pentacarbonyldiiron (7), and μ-[N-(6-methyl-2-pyridylmethylidene)-η²(C,N);η¹:η¹(S)-2- thiolethylamino]hexacarbonyldiiron (8). Reactions of both complex 7 and 8 with NOBF₄ gave μ-[(6-methyl-2-pyridylmethyl)-η¹(N_py);η¹:η¹(N);η¹:η¹(S)-2-thiolatoethylamido](acetonitrile)tricarbonylnitrosyldiiron (9). These reaction products were well characterized spectrally. The molecular structures of complexes 3, 7-9 have been determined by means of X-ray diffraction. Intramolecular 1,5-hydrogen shift from the thiol to the methine carbon was observed in complexes 3, 7, and 9.     

Synthesis,spectral characterization and biological evaluation of novel 1-(2-(4,5-dimethyl-2-phenyl-1H-imidazol-1-yl)ethyl)piperazine derivatives

A simple, highly useful synthesis of 1-(2-(4,5-dimethyl-2-phenyl-1H-imidazol-1-yl)ethyl)piperazine derivatives is achieved by a four component cyclo condensation of diacetyl, aromatic aldehyde, 2-(piperazin-1-yl)ethanamine and ammonium acetate using SO₄²⁻/Y₂O₃ as a catalyst in ethanol. The synthesized compounds were characterized by IR, ¹H and ¹³C NMR and mass spectral studies. All the synthesized compounds were screened for their in vitro antimicrobial studies. Among the newly synthesized compounds 5d, 5e, 5h and 5m showed excellent antibacterial and antifungal activities when compared to the standard drugs.     

2-(7-methyl-1H-benzoimidazol-2-yl)-6-(1-aryliminoethyl)pyridinylnickel complexes: Synthesis, characterization and their ethylene oligomerization

A series of 2-(methyl-substituted-1H-benzoimidazol-2-yl)-6-(1-aryliminoethyl)pyridines (L1–L6) were synthesized and used as N^N^N tridentate ligands for their nickel complexes (C1–C12). All ligands were fully characterized by elemental, NMR and IR spectroscopic analyses, while their nickel complexes were characterized by elemental and IR spectroscopic analyses. The single-crystal X-ray diffraction reveals that the complexes C1, C3 and C9 have distorted octahedral geometry around the Ni center. All nickel complexes, activated with Et₂AlCl, exhibit good catalytic activities toward ethylene oligomerization with major dimerization.     

Synthesis,characterization and crystal structures of 2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)-1-diazenyl]benzoic acid and its polymeric and monomeric triorganotin(IV) complexes

Three triorganotin(IV) complexes of composition R₃SnLH (R = Me, Bu and Ph and LH = 2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)-1-diazenyl]benzoate) have been synthesized and characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, and IR spectroscopic techniques in combination with elemental analysis. The crystal structures of the carboxylate ligand HO₂CC₆H₄{NN(C₆H₂-4-OH-3,5-(CH₃)₂)}-o in its neutral form and three triorganotin(IV) complexes, viz., polymeric (R₃Sn[O₂CC₆H₄{N–N(H)(C₆H₂-4-O-3,5-(CH₃)₂)}-o])_n (R = Me (1) and Bu (2)) and monomeric Ph₃Sn[O₂CC₆H₄{N–N(H)(C₆H₂-4-O-3,5-(CH₃)₂)}-o] (3) complexes are reported. The polymeric complexes 1 and 2 exist as extended chains in which the LH-bridged Sn-atoms adopt a trans-R₃SnO₂ trigonal bipyramidal configuration with R groups in the equatorial positions and the axial sites occupied by an oxygen atom from the carboxylate ligand and the phenoxide O atom of the next carboxylate ligand. The Sn atom in complex 3 has a distorted tetrahedral geometry. In all three complexes, the carboxylate ligand is in the zwitterionic form with the phenolic proton moved to the nearby azo nitrogen atom, in contrast to the free carboxylic acid ligand which is in the azo form.     

Stereospecific total synthesis of (+)-ε- and (-)-γ2-cadinene

(+)-ε-Cadinene (1) and (-)-γ₂cadinene (2) have been synthesized from the enol ether ketone 3 via the methylene ketone 4. These two stereospecific total syntheses confirm the structures assigned to these sesquiterpenes and represent the first preparation by totally synthetic methods of any of the widespread group of cadinanes in their native state.     

Synthesis,characterization and crystal structures of 2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)-1-diazenyl]benzoic acid and its polymeric and monomeric triorganotin(IV) complexes

Three triorganotin(IV) complexes of composition R₃SnLH (R = Me, Bu and Ph and LH = 2-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)-1-diazenyl]benzoate) have been synthesized and characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, and IR spectroscopic techniques in combination with elemental analysis. The crystal structures of the carboxylate ligand HO₂CC₆H₄{NN(C₆H₂-4-OH-3,5-(CH₃)₂)}-o in its neutral form and three triorganotin(IV) complexes, viz., polymeric (R₃Sn[O₂CC₆H₄{N–N(H)(C₆H₂-4-O-3,5-(CH₃)₂)}-o])_n (R = Me (1) and Bu (2)) and monomeric Ph₃Sn[O₂CC₆H₄{N–N(H)(C₆H₂-4-O-3,5-(CH₃)₂)}-o] (3) complexes are reported. The polymeric complexes 1 and 2 exist as extended chains in which the LH-bridged Sn-atoms adopt a trans-R₃SnO₂ trigonal bipyramidal configuration with R groups in the equatorial positions and the axial sites occupied by an oxygen atom from the carboxylate ligand and the phenoxide O atom of the next carboxylate ligand. The Sn atom in complex 3 has a distorted tetrahedral geometry. In all three complexes, the carboxylate ligand is in the zwitterionic form with the phenolic proton moved to the nearby azo nitrogen atom, in contrast to the free carboxylic acid ligand which is in the azo form.     

A short and efficient asymmetric synthesis of (1S,2R)-(+)-5-methoxy-1-methyl-2-(di-n-propylamino)tetralin hydrochloride (UH-232)

A general practical asymmetric synthesis of (1S,2R)-(+)-5-methoxy-1-methyl-2-(di-n-propylamino)tetralin hydrochloride (UH-232) was developed in a short and efficient method in high optical purity starting from commercially available 5-methoxy-1-tetralone. Asymmetric hydroboration of 5-methoxy-1-methyl-3,4-dihydronaphthalene with monoisopinocampheylborane followed by treatment with NaOH/H₂O₂ afforded key intermediate tetrahydronaphthol 4. Compound 4 was converted to the target molecule 1 using straightforward reactions.     

Experimental and theoretical studies on group 1 metallacarboranes: Synthesis, structure and ab initio calculations of the NMR chemical shifts of the 1-(THF)-1-(TMEDA)-1-Na-2,4-(SiMe3)2-2,4-C2B4H5 and related carboranes

The reaction of gaseous HCl with either the disodium or dilithium compound of the [nido-2,4-(SiMe₃)₂-2,4-C₂B₄H₄]²⁻ dianion (I) in 1:1 stoichiometry in THF produced the monoprotonated species 1-Na(THF)₂-2,4-(SiMe₃)₂-2,4-C₂B₄H₅ (II) or 1-Li(THF)₂-2,4-(SiMe₃)₂-2,4-C₂B₄H₅ (III), in 81% and 80% yields, respectively. This method proved superior to that involving the direct reduction of the closo-C₂B₄ carborane by metal hydrides. II and III were characterized by elemental analysis, ¹H, ¹¹B and ¹³C NMR and IR spectra. Compound II was recrystallized from a mixture THF, hexane and TMEDA (1:2:1) to isolate colorless crystals of the mixed solvated species, 1-(THF)-1-(TMEDA)-1-Na-2,4-(SiMe₃)₂-2,4-C₂B₄H₅ (IV), which were subsequently used for X-ray diffraction studies. The structure of IV showed that the capping metal occupied the apical position above the open C₂B₃ face of the carborane and that a hydrogen atom was bridging the two adjacent boron atoms on that face. The ¹¹B and ¹³C NMR spectra calculated by GIAO (gauge independent atomic orbital) methods at the 6-311G^** level on the B3LYP/6-31G^* optimized geometries of I–III, and a number of related nido- and closo-carboranes, gave excellent agreement with experiment, even in compounds where electron correlation effects are known to be important.     

Chemoenzymatic synthesis of enantiopure geminally dimethylated cyclopropane-based C2- and pseudo-C2-symmetric diamines

Enantiopure (−)-(1S,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxamide 2 and (+)-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylic acid 3 were easily obtained from a multigram scale biotransformation of racemic amide or nitrile in the presence of Rhodococcus erythropolis AJ270 whole cell catalyst under very mild conditions. Coupled with efficient and convenient chemical manipulations, comprising mainly of the Curtius rearrangement, oxidation, and reduction reactions, chiral C₂-symmetric (1S,2S)-3,3-dimethylcyclopropane-1,2-diamine 6 and ((1R,3R)-3-(aminomethyl)-2,2-dimethylcyclopropyl)methanamine 8 and pseudo-C₂-symmetric (1S,3S)-3-(aminomethyl)-2,2-dimethylcyclopropanamine 11 were prepared. These were also transformed into the corresponding chiral salen derivatives 12, 13, and 14, respectively, in almost quantitative yields.     

Copper(II) coordination chemistry of 2-methyl-2-(2-pyridyl)-1,3-propan-diol: Syntheses and structures of mono-, di-, and tricopper complexes

Six copper(II) complexes with N,O-donor ligand 2-methyl-2-(2-pyridyl)-1,3-propan-diol (H₂ppdo) were synthesized and characterized. Treatment of CuCl₂ or Cu(OTf)₂ with H₂ppdo led to the formation of bis(H₂ppdo) monomers [Cu(H₂ppdo)₂][CuCl₄] (1) and [Cu(H₂ppdo)₂](OTf)₂ (2), respectively. Both 1 and 2 are comprised of the copper atom coordinated by two ligands in an axially-compressed tetragonal geometry with the pyridyl N atoms in the axial positions and the alcohol O atoms in the equatorial plane. The treatment of 1 or 2 with Et₃N produced copper(II) complexes of varying nuclearity. Treatment of 1 with excess Et₃N generated two binuclear Cu(II) clusters [Cu₂(Hppdo)₂Cl₂] (3) and [Cu₂(Hppdo)₂Cl₂(CH₃OH)₂] (4), where only one alcohol OH group per ligand has been deprotonated, while similar treatment of 2 with excess Et₃N afforded the trimeric copper(II) species [Cu₃(Hppdo)₄](OTf)₂ (5). The structures of 3 and 4 are similar, with alkoxo-O ligand atoms bridging between two square pyramidal copper atoms, and the alcohol-O ligand atoms either coordinating in the axial position in 3, or uncoordinated in 4. Treatment of CuCl₂ with H₂ppdo and Et₃N afforded the trinuclear Cu(II) complex, [Cu₃(Hppdo)₄]Cl₂ (6). Complexes 5 and 6 are made up of one square-planar copper sandwiched between two tetragonally distorted six-coordinate Cu(Hppdo)₂ moieties, where the bridging alkoxo-O atoms link the copper atoms.     

Spectroscopic,anti-bacterial,anti-cancer and molecular docking of Pd(II) and Pt(II) complexes with (E)-4-((dimethylamino)methyl)-2-((4,5-dimethylthiazol-2-yl)diazenyl)phenol ligand

New ligand (E)-4-((dimethylamino)methyl)-2-((4,5-dimethylthiazol-2-yl)diazenyl)phenol (HDmazo) was prepared by the coupling reaction between 4,5-dimethylthiazol-2-amine and 4-((dimethylamino)methyl)phenol. Moreover, the [MCl₂(HDmazo)] and [M(HDmazo)₂] [M^II = Pd and Pt] were prepared using the direct reaction of equivalent molar of HDmazo and Na₂PdCl₄ or K₂PtCl₄. The HDmazo and its complexes were investigated by different spectroscopic techniques. In complexes (1–2) HDmazo ligand behaves as bidentate style through the nitrogen of azo group and nitrogen of thiazole ring towards Pd(II) and Pt(II). Or in a bidentate fashion via the oxygen atom of the hydroxylate group and nitrogen atom of azo group as mono-anion in complexes (3–4). Further, the study of biological activity against four pathogenic bacteria showed that compound (3) exhibited good activity compared to other compounds. Additional the anti-tumor action against A2870 cell lines was screened, and the complexes (1) and (2) displayed good activity with 7.45 ± 0.98 µM and 13.23 ± 1.43 µM, respectively. The binding mechanism of the prepared compounds with EGFR tyrosine kinase, was investigated using molecular docking experiments.     

Syntheses and structures of new luminescent B(III) complexes: BPh2(2-(2-pyridyl)naphtho[b]imidazole) and BF2(2-(2-pyridyl)naphtho[b]imidazole)

A novel chelating ligand, 2-(2-pyridyl)naphtho[b]imidazole (PNI) has been synthesized and structurally characterized. The PNI molecule reacts readily with BPh₃ and BF₃ to form BPh₂(2-(2-pyridyl)naphtho[b]imidazole) (1) and BF₂(2-(2-pyridyl)naphtho[b]imidazole) (2), respectively. The structures of PNI and 1 were determined by single crystal X-ray diffraction, while that 2 by spectroscopic methods. The structure of 1 reveals that the boron center is four-coordinated. The electroluminescent device using 1 as the emitting layer shows bright yellow luminescence with a maximum emission peak at 540 nm. Complexes 1 and 2 form a new family of organometallic emitting materials which could be of interest for practical applications.     

Synthesis, characterization and electroluminescence of B(III) compounds: BPh2(2-(2-quinolyl)naphtho[b]imidazolato) and BPh2(2-(2-quinolyl)benzimidazolato)

Two novel luminescent boron compounds, BPh₂(2-(2-quinolyl)naphtho[b]imidazolato) (1) and BPh₂(2-(2-quinolyl)benzimidazolato) (2), have been synthesized by the reactions of triphenylboron with appropriate ligands, 2-(2-quinolyl)naphtho[b]imidazole (QNI) and 2-(2-quinolyl)benzimidazole (QBI), respectively. The structure of 1 was determined by single crystal X-ray diffraction, while 2 by spectroscopic methods. The structure of 1 reveals that the boron center is four coordinated. Several types of OLED possessing different colors were fabricated by using 1 as emitter. For the three-layer OLED with the structure ITO/NPB/2/Alq₃/Mg-Ag, an emission band covering the whole visible region from 400 to 750 nm with the maximum brightness of 320 cd/m² was observed, indicating a perfect white light OLED (CIE = 0.33, 0.37). Compounds 1 and 2 form a new family of organometallic emitting materials which could be of interest for practical application.     

Synthesis,spectroscopic and crystal structure investigation of [Cu(bzsmp)2Cl2];{bzsmp = 2-benzylsulfanyl-5-(2-methoxyphenyl)-1,3,4-oxadiazole}: cyclization of N-[bis(benzylsulfanyl)methylene]-2-methoxybenzohydrazide to 2-benzylsulfanyl-5-(2-methoxyphenyl)-1,3,4 -oxadiazole during complexation

The ligand N²-[bis(benzylsulfanyl)methylene]-2-methoxybenzohydrazide (N²-bmbh) (1) on reaction with CuCl₂.2H₂O yielded the mononuclear complex [Cu(bzsmp)₂Cl₂] (2) (2-benzylsulfanyl-5-(2-methoxyphenyl)-1,3,4-oxadiazole, bzsmp). Complex 2 has been characterized by analytical, spectroscopic and X-ray data. X-ray study of 2 reveals that the cyclized ligand 2-benzylsulfanyl-5-(2-methoxyphenyl)-1,3,4-oxadiazole (bzsmp) acts as neutral bidentate ligand to form six membered chelate ring and the presence of C–H?π (face to edge) and C–H?S and two type of C–H?Cl weak interactions.